Search results for "mRNA platform concerns"

, Pfizer Vaccine, Adverse Event, Myocarditis, Pericarditis, Cardiology Referral, Medical Exemption, mRNA He stated that he received his first COVID-19 vaccine dose under pressure due to concerns about losing

Keywords from Transcript informed consent principles, voluntary consent requirement, coercion allegation, mRNA mask exemption termination, Human Rights complaint delay, pharmacy regulatory pressure, youth consent concerns 19 Response in Canada; November 2023 Main Topic Pharmacy vaccine rollout practices, informed consent concerns One Line Summary A former Alberta pharmacist raises concerns about informed consent, vaccine billing risks such as blood clots, responses from some pharmacists minimized uncertainty, and she expressed concern

natural immunity argument, ivermectin treatment advocacy, vaccine mandate opposition, control group concern public health political influence, lockdown psychiatric impact, coercion allegation, military attrition concern He expressed concern about adverse event reporting practices, coercive vaccine mandates, and the influence discussed his personal decision to receive the AstraZeneca vaccine for travel purposes while declining mRNA vaccines due to safety concerns, including potential immune and oncological implications.

and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Harm–Benefit Analysis of mRNA specializing in harm–benefit analysis, testified regarding his published reanalysis of the Pfizer and Moderna mRNA

Unvaccinated” label incident, vaccine coercion claim, Johnson & Johnson vaccine choice, pericarditis history concern , post-vaccination arthritis flare, informed consent concerns, shifting public health messaging Included He testified that he had a history of pericarditis and was hesitant about mRNA vaccines due to reported

Harding testified that during the early vaccine rollout he attempted to publish articles raising concerns about the speed of vaccine development and the use of mRNA technology. stated that submissions were rejected or discouraged by editorial outlets citing source credibility concerns

testimonies and findings from the 2023 NCI Report underscore the need for: Immediately Discontinuing Use of mRNA

for significant improvements in the adverse event reporting systems: Immediately Discontinuing Use of mRNA

breakthrough data, pediatric myocarditis modeling, biodistribution spike protein, reverse transcription concern 19 vaccine efficacy was misrepresented using relative risk figures, that safety and biodistribution concerns testified that shortly after relocating from the Mayo Clinic to Calgary in February 2020, he became concerned He raised concerns regarding antibody-dependent enhancement, immune imprinting, and evolutionary pressure He also discussed biodistribution findings, stating that mRNA and spike protein were detected beyond

One: Full Day Testimony Testimony alleging unprecedented safety signals in VAERS following COVID-19 mRNA rollout, concerns about spike protein toxicity, lipid nanoparticle distribution, and potential genomic Scientific and personal testimony criticizing pandemic policies, PCR testing practices, mRNA vaccine Concerns regarding censorship, pediatric COVID-19 vaccination policy, and government response including Retirement from the Canadian Armed Forces following refusal to comply with COVID-19 vaccination mandate and concerns

College of Physicians letter, media censorship La Presse, informed consent wording, pediatric vaccination concern He stated that he publicly questioned the characterization of mRNA products as conventional vaccines

rubella (MMR) vaccines and after her own research, she decided not to have her children receive the mRNA Renatej had serious fears that the government would forcibly inject or remove her children; she was concerned To address these concerns and prevent similar issues in the future, the following recommendations are These campaigns should use multiple platforms to reach diverse audiences. Encourage feedback and address concerns transparently.